Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.155 USD | -0.73% | +1.84% | -10.98% |
05-16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
05-02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
- Static Chart